Selected Publications
Authored by UF Health Cancer Center Members | 2021
*UF Health Cancer Center affiliates in bold.
Creelan BC, Wang C, Teer JK, Toloza EM, Yao J, Kim S, Landin AM, Mullinax JE, Saller JJ, Saltos AN, Noyes DR, Montoya LB, Curry W, Pilon-Thomas SA, Chiappori AA, Tanvetyanon T, Kaye FJ, Thompson ZJ, Yoder SJ, Fang B, Koomen JM, Sarnaik AA, Chen DT, Conejo-Garcia JR, Haura EB, Antonia SJ. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Nat Med. 2021 Aug;27(8):1410-1418. doi: 10.1038/s41591-021-01462-y. Epub 2021 Aug 12. PubMed PMID: 34385708; PubMed Central PMCID: PMC8509078.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O’Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S1470-2045(20)30540-4. Epub 2020 Nov 27. PubMed PMID: 33253641; PubMed Central PMCID: PMC7988888.
Zhu G, Luo H, Feng Y, Guryanova OA, Xu J, Chen S, Lai Q, Sharma A, Xu B, Zhao Z, Feng R, Ni H, Claxton D, Guo Y, Mesa RA, Qiu Y, Yang FC, Li W, Nimer SD, Huang S, Xu M. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia. Nat Commun. 2021 Mar 29;12(1):1956. doi: 10.1038/s41467-021-22095-2. PubMed PMID: 33782403; PubMed Central PMCID: PMC8007823.
Prasanna PG, Citrin DE, Hildesheim J, Ahmed MM, Venkatachalam S, Riscuta G, Xi D, Zheng G, Deursen JV, Goronzy J, Kron SJ, Anscher MS, Sharpless NE, Campisi J, Brown SL, Niedernhofer LJ, O’Loghlen A, Georgakilas AG, Paris F, Gius D, Gewirtz DA, Schmitt CA, Abazeed ME, Kirkland JL, Richmond A, Romesser PB, Lowe SW, Gil J, Mendonca MS, Burma S, Zhou D, Coleman CN. Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy. J Natl Cancer Inst. 2021 Oct 1;113(10):1285-1298. doi: 10.1093/jnci/djab064. PubMed PMID: 33792717; PubMed Central PMCID: PMC8486333.
Wagner AD, Grothey A, Andre T, Dixon JG, Wolmark N, Haller DG, Allegra CJ, de Gramont A, VanCutsem E, Alberts SR, George TJ, O’Connell MJ, Twelves C, Taieb J, Saltz LB, Blanke CD, Francini E, Kerr R, Yothers G, Seitz JF, Marsoni S, Goldberg RM, Shi Q. Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34640 Patients in the ACCENT Database. J Natl Cancer Inst. 2021 Apr 6;113(4):400-407. doi: 10.1093/jnci/djaa124. PubMed PMID: 32835356; PubMed Central PMCID: PMC8023830.
Dominguez-Gutierrez PR, Kwenda EP, Donelan W, O’Malley P, Crispen PL, Kusmartsev S. Hyal2 Expression in Tumor-Associated Myeloid Cells Mediates Cancer-Related Inflammation in Bladder Cancer. Cancer Res. 2021 Feb 1;81(3):648-657. doi: 10.1158/0008-5472.CAN-20-1144. Epub 2020 Nov 25. PubMed PMID: 33239427.
Kazi A, Chen L, Xiang S, Vangipurapu R, Yang H, Beato F, Fang B, Williams TM, Husain K, Underwood P, Fleming JB, Malafa M, Welsh EA, Koomen J, Trevino J, Sebti SM. Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer. Clin Cancer Res. 2021 Jul 15;27(14):4012-4024. doi: 10.1158/1078-0432.CCR-20-4781. Epub 2021 Apr 20. PubMed PMID: 33879459; PubMed Central PMCID: PMC8493485.
Wolfe AR, Robb R, Hegazi A, Abushahin L, Yang L, Shyu DL, Trevino JG, Cruz-Monserrate Z, Jacob JR, Palanichamy K, Chakravarti A, Williams TM. Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer. Clin Cancer Res. 2021 Jan 15;27(2):554-565. doi: 10.1158/1078-0432.CCR-20-1422. Epub 2020 Oct 21. PubMed PMID: 33087331; PubMed Central PMCID: PMC7855515.
Brown PA, Kairalla JA, Hilden JM, Dreyer ZE, Carroll AJ, Heerema NA, Wang C, Devidas M, Gore L, Salzer WL, Winick NJ, Carroll WL, Raetz EA, Borowitz MJ, Small D, Loh ML, Hunger SP. FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631. Leukemia. 2021 May;35(5):1279-1290. doi: 10.1038/s41375-021-01177-6. Epub 2021 Feb 23. Erratum in: Leukemia. 2021 Apr 12;:. PubMed PMID: 33623141; PubMed Central PMCID: PMC8763141.
Sempere LF, Powell K, Rana J, Brock AA, Schmittgen TD. Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer. Cancer Metastasis Rev. 2021 Sep;40(3):761-776. doi: 10.1007/s10555-021-09995-x. Epub 2021 Sep 30. Review. PubMed PMID: 34591242; PubMed Central PMCID: PMC8556175.
Chen Z, Ni W, Li JL, Lin S, Zhou X, Sun Y, Li JW, Leon ME, Hurtado MD, Zolotukhin S, Liu C, Lu J, Griffin JD, Kaye FJ, Wu L. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma. JCI Insight. 2021 Apr 8;6(7). pii: 139497. doi: 10.1172/jci.insight.139497. PubMed PMID: 33830080; PubMed Central PMCID: PMC8119194.
Sahin I, George A, Seyhan AA. Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers. Int J Mol Sci. 2021 Oct 30;22(21). pii: 11790. doi: 10.3390/ijms222111790. Review. PubMed PMID: 34769221; PubMed Central PMCID: PMC8583749.
George TJ, Ali A, Wang Y, Lee JH, Ivey AM, DeRemer D, Daily KC, Allegra CJ, Hughes SJ, Fan ZH, Cameron ME, Judge AR, Trevino JG. Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma. Oncologist. 2021 Oct;26(10):825-e1674. doi: 10.1002/onco.13853. Epub 2021 Jun 23. PubMed PMID: 34101295; PubMed Central PMCID: PMC8488773.
Lopusna K, Nowialis P, Opavska J, Abraham A, Riva A, Haney SL, Opavsky R. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice. J Biol Chem. 2021 Jan-Jun;296:100285. doi: 10.1016/j.jbc.2021.100285. Epub 2021 Jan 13. PubMed PMID: 33450231; PubMed Central PMCID: PMC7949038.
Tanaka M, Dykes SS, Siemann DW. Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling. Clin Exp Metastasis. 2021 Jun;38(3):321-335. doi: 10.1007/s10585-021-10093-z. Epub 2021 Mar 31. PubMed PMID: 33791875; PubMed Central PMCID: PMC8179919.
Hu Q, Upadhyaya P, Hecht SS, Aly FZ, Huo Z, Xing C. Characterization of adductomic totality of NNK, (R)-NNAL, and (S)-NNAL in A/J mice, and their correlations with distinct lung carcinogenicity. Carcinogenesis. 2021 Dec 17. pii: bgab113. doi: 10.1093/carcin/bgab113. [Epub ahead of print] PubMed PMID: 34919675.
Jo A, Scarton L, O’Neal LJ, Larson S, Schafer N, George TJ, Munoz Pena JM. New onset of type 2 diabetes as a complication after cancer diagnosis: A systematic review. Cancer Med. 2021 Jan;10(2):439-446. doi: 10.1002/cam4.3666. Epub 2020 Dec 23. PubMed PMID: 33355998; PubMed Central PMCID: PMC7877369.
Hong YR, Yadav S, Suk R, Khanijahani A, Erim D, Turner K. Patient-provider discussion about emotional and social needs, mental health outcomes, and benefit finding among U.S. Adults living with cancer. Cancer Med. 2021 Jun;10(11):3622-3634. doi: 10.1002/cam4.3918. Epub 2021 May 7. PubMed PMID: 33960716; PubMed Central PMCID: PMC8178502.
Guo Y, Szurek SM, Bian J, Braithwaite D, Licht JD, Shenkman EA. The role of sex and rurality in cancer fatalistic beliefs and cancer screening utilization in Florida. Cancer Med. 2021 Sep;10(17):6048-6057. doi: 10.1002/cam4.4122. Epub 2021 Jul 13. PubMed PMID: 34254469; PubMed Central PMCID: PMC8419763.
Zhou X, Li C, Zhang Z, Li DY, Du J, Ding P, Meng H, Xu H, Li R, Ho E, Zhang A, Okunieff P, Lu J, Sha MY. Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients. Sci Rep. 2021 Apr 7;11(1):7633. doi: 10.1038/s41598-021-85797-z. PubMed PMID: 33828112; PubMed Central PMCID: PMC8027214.
Zhang D, Abraham L, Demb J, Miglioretti DL, Advani S, Sprague BL, Henderson LM, Onega T, Wernli KJ, Walter LC, Kerlikowske K, Schousboe JT, O’Meara ES, Braithwaite D; Breast Cancer Surveillance Consortium. Function-related Indicators and Outcomes of Screening Mammography in Older Women: Evidence from the Breast Cancer Surveillance Consortium Cohort. Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1582-1590. doi: 10.1158/1055-9965.EPI-21-0152. Epub 2021 Jun 2. PubMed PMID: 34078641; PubMed Central PMCID: PMC8563300.
Medikonda R, Dunn G, Rahman M, Fecci P, Lim M. A review of glioblastoma immunotherapy. J Neurooncol. 2021 Jan;151(1):41-53. doi: 10.1007/s11060-020-03448-1. Epub 2020 Apr 6. Review. PubMed PMID: 32253714.
Suarez-Martinez AD, Sole-Gras M, Dykes SS, Wakefield ZR, Bauer K, Majbour D, Bundy A, Pampo C, Burow ME, Siemann DW, Huang Y, Murfee WL. Bioprinting on Live Tissue for Investigating Cancer Cell Dynamics. Tissue Eng Part A. 2021 Apr;27(7-8):438-453. doi: 10.1089/ten.TEA.2020.0190. Epub 2020 Nov 18. PubMed PMID: 33059528; PubMed Central PMCID: PMC8349716.
Huo J, Hong YR, Turner K, Chen C, Guo Y, Wilkie DJ, Bian J. Geographic variation in palliative care delivery among patients diagnosed with metastatic lung cancer in the USA: Medicare population-based study. Support Care Cancer. 2021 Feb;29(2):813-821. doi: 10.1007/s00520-020-05549-z. Epub 2020 Jun 4. PubMed PMID: 32495033.
Bearrick EN, Packiam V, Bhindi B, Lohse CM, Cheville JC, Mason RJ, Tollefson M, Harrington S, Dong H, Parker AS, Boorjian SA, Thompson RH, Leibovich BC. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma. Urol Oncol. 2021 Feb;39(2):135.e1-135.e8. doi: 10.1016/j.urolonc.2020.08.028. Epub 2020 Dec 9. PubMed PMID: 33309297.
Wen KW, Joseph NM, Srivastava A, Saunders TA, Jain D, Rank J, Feely M, Zarrinpar A, Al Diffalha S, Shyn PB, Graham RP, Drage MG, Kakar S. Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma. Hum Pathol. 2021 Oct;116:82-93. doi: 10.1016/j.humpath.2021.07.004. Epub 2021 Jul 20. PubMed PMID: 34298064.
Zhang R, Yang X, Roque DM, Li C, Lin J. A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin. PLoS One. 2021 Apr 28;16(4):e0240145. doi: 10.1371/journal.pone.0240145. eCollection 2021. PubMed PMID: 33909625; PubMed Central PMCID: PMC8081214.
Deming AC, Wellehan JFX, Colegrove KM, Hall A, Luff J, Lowenstine L, Duignan P, Cortés-Hinojosa G, Gulland FMD. Unlocking the Role of a Genital Herpesvirus, Otarine Herpesvirus 1, in California Sea Lion Cervical Cancer. Animals (Basel). 2021 Feb 13;11(2). pii: 491. doi: 10.3390/ani11020491. PubMed PMID: 33668446; PubMed Central PMCID: PMC7918579.
Fredenburg KM, Whitlock J, Morris C, Kirwan J, Silver NL, Ragin C, Parker A, Mendenhall WM. Lower disease control rates and survival outcomes among Blacks with pharyngeal squamous cell carcinomas compared with Whites: a retrospective analysis at the University of Florida. Cancer Causes Control. 2021 Nov;32(11):1269-1278. doi: 10.1007/s10552-021-01477-3. Epub 2021 Jul 14. PubMed PMID: 34259972.
Cascio MJ, Whitley EM, Sahay B, Cortes-Hinojosa G, Chang LJ, Cowart J, Salute M, Sayour E, Dark M, Sandoval Z, Mitchell DA, Milner RJ. Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate. Vet Immunol Immunopathol. 2021 Feb;232:110169. doi: 10.1016/j.vetimm.2020.110169. Epub 2020 Dec 15. PubMed PMID: 33387703.
Paige SR, Alpert JM, Bylund CL. Fatalistic Cancer Beliefs Across Generations and Geographic Classifications: Examining the Role of Health Information Seeking Challenges and Confidence. J Cancer Educ. 2021 Feb;36(1):3-9. doi: 10.1007/s13187-020-01820-3. PubMed PMID: 32648238; PubMed Central PMCID: PMC7794083.
Paige SR, Salloum RG, Carter-Harris L. Assessment of Lung Cancer Screening Eligibility on NCI-Designated Cancer Center Websites. J Cancer Educ. 2021 Sep 3. doi: 10.1007/s13187-021-02051-w. [Epub ahead of print] PubMed PMID: 34478042.
Mochona B, Lyon D, Offringa IA, Redda KK, Reams RR, Odedina F, Wilkie DJ, Stern MC, Carpten JD. Developing a Novel Framework for an Undergraduate Cancer Research Education and Engagement Program for Underrepresented Minority Students: the Florida-California CaRE(2) Research Education Core (REC) Training Program. J Cancer Educ. 2021 Oct;36(5):914-919. doi: 10.1007/s13187-020-01762-w. PubMed PMID: 32430639; PubMed Central PMCID: PMC7674268.
Anie HNA, Rotimi SO, Fernandez P, Rodrigues B, Fatiregun OA, Lasebikan N, Wilson S, Osman K, Nyoni L, Newman L, Odedina FT. Report of the Premier African Organisation for Research and Training in Cancer Virtual Genomics Conference held from 18-20 February 2021. Ecancermedicalscience. 2021 Jun 21;15:1253. doi: 10.3332/ecancer.2021.1253. eCollection 2021. PubMed PMID: 34267809; PubMed Central PMCID: PMC8241447.